Literature DB >> 23442006

Composition of artificial tear solution affects in vitro Pseudomonas aeruginosa biofilm formation on silicone hydrogel lens.

Mukesh Kumar Yadav1, Roy S Chuck, Choul Yong Park.   

Abstract

PURPOSE: To investigate Pseudomonas aeruginosa biofilm formation on silicone hydrogel contact lens in various artificial tears.
METHODS: P. aeruginosa was cocultured with contact lenses (Senofilcon A, Acuvue Oasys Hydraclear plus(®); Johnson & Johnson, Jacksonville, FL) in artificial tears containing hyaluronic acid (HA) (0.3%, 0.1%, or 0.1%+benzalkonium chloride) or carboxymethylcellulose (0.5% or 0.3%+dextran). P. aeruginosa biofilm was stained with crystal violet (0.1%) after 48 h of incubation. The optical density of the dissolved biofilm was measured by a spectrophotometer at 570 nm and was compared.
RESULTS: P. aeruginosa biofilm formation in 3 solutions (0.3% HA, 0.1% HA+benzalkonium chloride and 0.3% carboxymethylcellulose+dextran) was significantly decreased compared to the other 2 solutions (0.1% HA and 0.5% carboxymethylcellulose) (P<0.01).
CONCLUSIONS: P. aeruginosa biofilm formation on silicone hydrogel contact lens was affected by the composition of artificial tears. A higher concentration of HA and addition of benzalkonium chloride or dextran in artificial tears were helpful to prevent P. aeruginosa biofilm formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23442006     DOI: 10.1089/jop.2012.0078

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  2 in total

1.  In vitro microbicidal, anti-biofilm and cytotoxic effects of different commercial antiseptics.

Authors:  Silvestre Ortega-Peña; Christian Hidalgo-González; Martin C Robson; Edgar Krötzsch
Journal:  Int Wound J       Date:  2016-06-10       Impact factor: 3.315

2.  Effects of Sodium Hyaluronate Eye Drops With or Without Preservatives on Ocular Surface Bacterial Microbiota.

Authors:  Yanlin Zhong; Xie Fang; Xuemei Wang; Yu-An Lin; Huping Wu; Cheng Li
Journal:  Front Med (Lausanne)       Date:  2022-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.